Literature DB >> 29356584

Self-Reactive B Cells in the Germinal Center Reaction.

Robert Brink1,2, Tri Giang Phan1,2.   

Abstract

Maintenance of immunological self-tolerance requires lymphocytes carrying self-reactive antigen receptors to be selectively prevented from mounting destructive or inflammatory effector responses. Classically, self-tolerance is viewed in terms of the removal, editing, or silencing of B and T cells that have formed self-reactive antigen receptors during their early development. However, B cells activated by foreign antigen can enter germinal centers (GCs), where they further modify their antigen receptor by somatic hypermutation (SHM) of their immunoglobulin genes. The inevitable emergence of activated, self-reactive GC B cells presents a unique challenge to the maintenance of self-tolerance that must be rapidly countered to avoid autoantibody production. Here we discuss current knowledge of the mechanisms that enforce B cell self-tolerance, with particular focus on the control of self-reactive GC B cells. We also consider how self-reactive GC B cells can escape self-tolerance to initiate autoantibody production or instead be redeemed via SHM and used in productive antibody responses.

Keywords:  Tfh cells; autoantibodies; plasma cells; self-tolerance; somatic hypermutation

Mesh:

Substances:

Year:  2018        PMID: 29356584     DOI: 10.1146/annurev-immunol-051116-052510

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  28 in total

Review 1.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

Review 2.  Innate B Cells: the Archetype of Protective Immune Cells.

Authors:  Alexis Grasseau; Marina Boudigou; Laëtitia Le Pottier; Nedra Chriti; Divi Cornec; Jacques-Olivier Pers; Yves Renaudineau; Sophie Hillion
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 3.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

4.  Functional Characterization of CD11c+ Age-Associated B Cells as Memory B Cells.

Authors:  Samuel W Du; Tanvi Arkatkar; Fahd Al Qureshah; Holly M Jacobs; Christopher D Thouvenel; Kristy Chiang; Andrea D Largent; Quan-Zhen Li; Baidong Hou; David J Rawlings; Shaun W Jackson
Journal:  J Immunol       Date:  2019-10-21       Impact factor: 5.422

5.  Excessive CD11c+Tbet+ B cells promote aberrant TFH differentiation and affinity-based germinal center selection in lupus.

Authors:  Wenqian Zhang; Huihui Zhang; Shujun Liu; Fucan Xia; Zijian Kang; Yan Zhang; Yaoyang Liu; Hui Xiao; Lei Chen; Chuanxin Huang; Nan Shen; Huji Xu; Fubin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

Review 6.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

Review 7.  B Cell Aberrance in Lupus: the Ringleader and the Solution.

Authors:  YuXue Nie; Lidan Zhao; Xuan Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-03       Impact factor: 8.667

Review 8.  B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells.

Authors:  Carlo G Bonasia; Wayel H Abdulahad; Abraham Rutgers; Peter Heeringa; Nicolaas A Bos
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

Review 9.  B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies.

Authors:  Maria T Cencioni; Miriam Mattoscio; Roberta Magliozzi; Amit Bar-Or; Paolo A Muraro
Journal:  Nat Rev Neurol       Date:  2021-06-01       Impact factor: 42.937

Review 10.  T Follicular Regulatory Cells: Choreographers of Productive Germinal Center Responses.

Authors:  Yisi Lu; Joe Craft
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.